Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey.
about
Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infectionThe place of immunotherapy in the management of HCV-induced vasculitis: an updateGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Vasculitis with renal involvement in essential mixed cryoglobulinemia: Case report and mini-reviewManaging refractory cryoglobulinemic vasculitis: challenges and solutionsApplication of marginal structural models in pharmacoepidemiologic studies: a systematic review.The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients.Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN.A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren's syndrome.Vasculitic emergencies in the intensive care unit: a special focus on cryoglobulinemic vasculitis.B Cells, Antibodies, and More.Renal vasculitis in 2012: reclassification and the introduction of biologicals.Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review.Cutaneous vasculitis: a rheumatologist perspective.Diagnostics and treatment of cryoglobulinaemia: it takes two to tango.Non-infectious cryoglobulinemia vasculitis (CryoVas): update on clinical and therapeutic approach.Rheumatological diseases and kidneys: a nephrologist's perspective.Renal involvement in primary Sjögren's syndrome.Renal involvement in primary Sjögren syndrome.Management of Small Vessel Vasculitides.Paraprotein-Related Kidney Disease: Glomerular Diseases Associated with Paraproteinemias.Resolution of Q Fever-Associated Cryoglobulinemia With Anti-CD20 Monoclonal Antibody Treatment.Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis.Rituximab therapy for primary glomerulonephritis: Report on two casesInteractions between virus-related factors and post-transplant ascites in patients with hepatitis C and no cirrhosis: role of cryoglobulinemia.Rituximab for Sjögren syndrome-associated type II mixed cryoglobulinemic cerebral vasculitis.Flare of essential mixed cryoglobulinemic vasculitis with hemorrhagic bullous purpura after rituximab infusion.Membranoproliferative glomerulonephritis: the times they are a-changin'.Long-term outcome of monoclonal (type 1) cryoglobulinemia.Investigational drugs in systemic vasculitis.Guidelines on the diagnosis and management of Waldenström macroglobulinaemia.Pediatric cryoglobulinemic vasculitis successfully managed with rituximab
P2860
Q24187162-CE3DDFEF-458A-4A08-8EE5-3203C0FDFC66Q27015124-317C37A9-DB2B-40A2-A9A5-B9744250DF9EQ30276550-CE49D48A-6C48-4E80-A6CB-605F8199C117Q33621208-B4DCF5A2-C999-43BA-AF20-EAC015698E69Q33673888-D63CFE8B-D2AC-4967-9E40-FFDC2EDF0329Q33707284-F6C9029A-F0F5-4DDA-9BC1-9EDB2AF31CCFQ35408908-8191CE41-1E0E-420B-AE59-40484DBD0963Q35741844-BD545F3C-A688-4BC7-AEDE-1C6F938FA42AQ36219673-2D4B3ED0-CD98-4DCF-B567-5A2394BDA530Q36368134-E74938A4-448C-484B-8EE0-BA4D4F5FDDA9Q36432935-0E6E2315-8263-449D-84AC-C25EEC5D5680Q38072294-C222D0BA-A0B2-459E-B6EE-59E2F576FB38Q38101526-0F1CBDE4-7999-4D41-84C3-F040013E8251Q38119877-D2990CB7-E9CD-4B63-9D40-385945D974CCQ38143718-D64A2AED-2145-4446-92E1-8CF4D3887D1BQ38197547-202AB766-B384-4468-81B4-00ACFECA096BQ38222239-EE76302F-53D9-4128-873B-13624D7CDD68Q38526786-04218BC6-1291-4710-8693-0B0DFB7BAD7AQ38633492-17FD419F-845B-47F1-B670-4FACA8E39CD6Q38818682-D87602F5-2211-4C51-81B4-8487A91FB1DFQ38831139-221AEDA7-B817-4F34-AEA9-5B231BB3991BQ40068762-DE071DB8-272E-45F5-A70F-0CB144660ED9Q40362365-1A99E293-7C04-4DB5-BEA7-D999B661638EQ41036642-3CA380CD-83EF-4BA0-9031-8C7B85057E8FQ41722162-01A6DFB4-C2A7-42ED-B4FA-516EE4316E29Q42413961-6A8FB024-3895-4844-874B-BC3511E3FCBBQ44486898-766E78D8-9532-425A-A427-0E0A1D3F8C3EQ47685392-EA787E5D-0B67-4F19-8114-4FDA06478DA5Q50721391-C85EC537-8E18-4ED3-BC3E-7D70CE35A0D9Q51834131-E6DCED60-57F3-4848-A11F-6E15ADAE5DDBQ52840250-2D3D16B3-3F9C-4877-81EA-4B6CA8612026Q58428977-DFC88F95-3E81-4839-8A2D-D0648F333A02
P2860
Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Management of noninfectious mi ...... ncluded in the CryoVas survey.
@ast
Management of noninfectious mi ...... ncluded in the CryoVas survey.
@en
Management of noninfectious mi ...... ncluded in the CryoVas survey.
@nl
type
label
Management of noninfectious mi ...... ncluded in the CryoVas survey.
@ast
Management of noninfectious mi ...... ncluded in the CryoVas survey.
@en
Management of noninfectious mi ...... ncluded in the CryoVas survey.
@nl
prefLabel
Management of noninfectious mi ...... ncluded in the CryoVas survey.
@ast
Management of noninfectious mi ...... ncluded in the CryoVas survey.
@en
Management of noninfectious mi ...... ncluded in the CryoVas survey.
@nl
P2093
P50
P1433
P1476
Management of noninfectious mi ...... ncluded in the CryoVas survey.
@en
P2093
Adeline Lacraz
Antoine Huart
Benjamin Terrier
Elisabeth Diot
Emmanuelle Plaisier
Estibaliz Lazaro
Evguenia Krastinova
Fabrice Bonnet
Frank Bridoux
Guillaume Le Guenno
P304
P356
10.1182/BLOOD-2011-12-396028
P407
P577
2012-04-03T00:00:00Z